Adam Egry

Adam Egry is the Business Unit Head for Cardiovascular, Renal and Metabolism at AstraZeneca, where they currently work. They served as a Commercial Director at Neuraxpharm and previously held leadership roles at Sanofi and Sandoz, among others, demonstrating extensive experience in the pharmaceutical and FMCG sectors. Adam began their career at Johnson & Johnson and has since cultivated a robust background in brand and trade marketing. They hold a Master of Science in Business and Management from the University of Pécs and a Bachelor of Science in Commerce and Marketing from Budapest Business School.